J&J expects to file for 14 new drugs by 2025
Over the current book year the total revenue will be 94.25 billion USD (consensus estimates). This is hugely more than 2021's revenue of 82.58 billion USD.
Historical revenues and results Johnson & Johnson plus estimates 2021
The analysts expect for 2021 a net profit of 26.16 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 9.8 USD. The price/earnings-ratio therefore equals 16.62.
Per share the analysts anticipate on a dividend of 4.16 USD per share. The dividend yield is then 2.55 percent. The average dividend yield of the health care companies equals a limited 1.27 percent.
Based on the current number of outstanding shares Johnson & Johnson 's market capitalization 428.81 billion USD. 14
On Friday the stock closed at 162.89 USD.Historical stock prices Johnson & Johnson
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
